Skip to main content

Hepatitis C News (Page 4)

Related terms: Hepatitis C, Chronic, Chronic Hepatitis C, Hep C

FDA Medwatch Alert: Victrelis (boceprevir) and Ritonavir-Boosted Human Immunodeficiency Virus (HIV) Protease Inhibitor Drugs: Drug Safety Communication - Drug Interactions

[UPDATED 04/26/2012] FDA notified healthcare professionals that the Victrelis drug label has been revised to state that co-administration of Victrelis (boceprevir), a hepatitis C virus (HCV) protease...

FDA Approves Incivek (telaprevir) for People with Hepatitis C

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated today announced that the U.S. Food and Drug Administration (FDA) has approved Incivek (telaprevir) tablets for a broad group...

FDA Approves Merck's Victrelis (boceprevir), First-in-Class Oral Hepatitis C Virus (HCV) Protease Inhibitor

WHITEHOUSE STATION, N.J., May 13, 2011 – Merck (known as MSD outside the United States and Canada) announced today that the U.S. Food and Drug Administration (FDA) has approved Victrelis (...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related drug support groups

Epclusa, Mavyret, Harvoni